Conference report: Pharmaceutical development of biologics: Fundamentals, challenges and recent advances

Therapeutic Delivery

Volumn 2, Issue 7, 2011, Pages 865-871

  Su, Jing ^a   Mazzeo, Jeffrey ^b   Subbarao, Nanda ^c   Jin, Tuo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b WATERS CORPORATION   (United States)

^c Biologics Consulting Group Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BIOLOGICAL PRODUCT; INSULIN DERIVATIVE; LIPOFECTAMINE; LIPOSOME; MICROSPHERE; MONOCLONAL ANTIBODY; NUCLEOTIDE DERIVATIVE; PHOSPHOLIPID; POLOXAMER; POLYGLACTIN; POLYSACCHARIDE; POLYVINYL ALCOHOL; RECOMBINANT DNA; SMALL INTERFERING RNA; BIOSIMILAR AGENT; PROTEIN;

ANALYTIC METHOD; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG PACKAGING; DRUG PURIFICATION; DRUG RESEARCH; DRUG STABILITY; DRUG STORAGE; EMULSION; FREEZE DRYING; HUMAN; HYDROGEL; MICROENCAPSULATION; NONHUMAN; PHOSPHOLIPID BILAYER; PHYSICAL CHEMISTRY; PREFORMULATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN STABILITY; SUSTAINED RELEASE FORMULATION; THERMODYNAMICS; TRANSDERMAL PATCH; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG INDUSTRY; METHODOLOGY; PHARMACEUTICS;

BIOSIMILAR PHARMACEUTICALS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG INDUSTRY; HUMANS; PROTEINS; TECHNOLOGY, PHARMACEUTICAL;

EID: 79961187823     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.11.58     Document Type: Conference Paper

References (9)

1. Shire S. Aggregation and potential impact on safety and physical properties of protein biotherapeutics. Presented at: AAPS 46th Arden Conference: Pharmaceutical Development of Biologics: Fundamentals, Challenges and Recent Advances. West Point, NY, USA, 6-11 March 2011.
2. Jin T, Yuan WE, Hu ZH. Die-hard challenges in sustained-release protein formulations: reducing initial burst and maintaining drug conformational stability simultaneously. Presented at: AAPS 46th Arden Conference: Pharmaceutical Development of Biologics: Fundamentals, Challenges and Recent Advances. West Point, NY, USA, 6-11 March 2011.
3. Jin T, Zhu JH, Zhu H et al. Preparing polymer-based sustained-release systems without exposing proteins to water/oil or water/air interfaces and cross-linking reagents. J. Control. Release 128, 50-59 (2008).
4. Perlin DS. Amphotericin B cochleates: a vehicle for oral delivery. Curr. Opin. Investig. Drugs 5, 198-201 (2004).
5. Lambert WJ, Los K. DepoFoam® multivesicular liposomes for the sustained release of macromolecules. In:Modified- Release Drug Delivery Technology (Second Edition). Rathbone MJ, Roberts MS (Eds).Informa Healthcare, 2, 207-214 (2008).
6. Tomlinson E. Recent advances in transdermal delivery of biologics and major hurdles to commercialization. Presented at: AAPS 46th Arden Conference: Pharmaceutical Development of Biologics: Fundamentals, Challenges and Recent Advances. West Point, NY, USA, 6-11 March 2011.
7. Thorne RG, Pronk GJ, Frey II WH et al. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127, 481-496 (2004). (Pubitemid 38950662)
8. Betancourt T, Peppas LB. Micro- and nanofabrication methods in nanotechnological medical and pharmaceutical devices. Int. J. Nanomed. 1, 483-495(2006).
9. Ye Q, Park K. Recent advances in hydrogel drug delivery for biotherapeutics and major hurdles to commercialization. Presented at: AAPS 46th Arden Conference: Pharmaceutical Development of Biologics: Fundamentals, Challenges and Recent Advances. West Point, NY, USA, 6-11 March 2011.